Prestige Consumer Healthcare Q3 Earnings Miss Expectations
- Earnings Report Disappointment: Prestige Consumer Healthcare reported a Q3 non-GAAP EPS of $1.14, missing expectations by $0.02, indicating pressure on profitability that could affect investor confidence.
- Revenue Decline: Q3 revenue was $283.4 million, down 2.4% year-over-year and missing market expectations by $3.12 million, reflecting challenges in the competitive landscape.
- Fiscal 2026 Outlook Adjustment: The company revised its FY26 revenue outlook to between $1.1 billion and $1.115 billion, indicating a cautious stance on future growth with an anticipated organic revenue decline of approximately 3%.
- Stable Cash Flow: Despite challenges, the company expects free cash flow to remain at $245 million or more, demonstrating robust cash management that may support future investments.
Trade with 70% Backtested Accuracy
Analyst Views on PBH
About PBH
About the author
Prestige Consumer Healthcare Q3 Earnings Miss Expectations
- Earnings Report Disappointment: Prestige Consumer Healthcare reported a Q3 non-GAAP EPS of $1.14, missing expectations by $0.02, indicating pressure on profitability that could affect investor confidence.
- Revenue Decline: Q3 revenue was $283.4 million, down 2.4% year-over-year and missing market expectations by $3.12 million, reflecting challenges in the competitive landscape.
- Fiscal 2026 Outlook Adjustment: The company revised its FY26 revenue outlook to between $1.1 billion and $1.115 billion, indicating a cautious stance on future growth with an anticipated organic revenue decline of approximately 3%.
- Stable Cash Flow: Despite challenges, the company expects free cash flow to remain at $245 million or more, demonstrating robust cash management that may support future investments.
2026 Stock Market and Economic Forecast from Barron’s Roundtable Experts
Market Concerns: Investors are increasingly worried about high valuations, index concentration, circular finance, persistent inflation, and rising government debt.
Geopolitical Developments: A significant geopolitical event occurred on January 3, with the capture of Venezuelan President Nicolás Maduro and his wife by U.S. troops, adding to market uncertainties.
Prestige Consumer Acquires Pillar5 Pharma to Expand Eye Care Product Line
- E-Commerce Growth: Prestige Consumer reported double-digit consumption growth in e-commerce channels, with online sales representing up to 20% of total sales in fiscal 2025, reflecting the success of its digital strategies and enhancing market competitiveness.
- Acquisition Fuels Growth: The company announced the acquisition of Pillar5 Pharma, expected to close in Q3 of fiscal 2026, which will enhance supply capabilities in the eye care category, securing near-term supply and expanding long-term production capacity, thereby diversifying its product portfolio.
- Stable Solvency: As of the end of Q2 fiscal 2026, Prestige Consumer reported no short-term debt and cash equivalents of $119 million, indicating a robust financial position that helps mitigate risks from economic fluctuations.
- Cost Pressure Challenges: Despite facing approximately $5 million in tariff costs and supply chain disruptions, Prestige Consumer is proactively implementing cost-saving measures and tactical pricing strategies to offset these impacts, ensuring sustained profitability.
Premium Brands Acquires Stampede for $662.5 Million
- Acquisition Agreement: Premium Brands has entered into a definitive agreement to acquire Stampede Culinary Partners for approximately $662.5 million, consisting of $512.5 million in cash and $150 million in common shares, which is expected to significantly enhance its position in the U.S. foodservice market.
- Market Expansion: This acquisition will strengthen Premium Brands' presence in the U.S. foodservice channel, particularly as its current strategies are primarily focused on retail and club store channels, thereby driving overall company growth.
- Production Capability Enhancement: By acquiring Stampede, Premium Brands will gain sous vide cooking capabilities, enhancing its production capacity and is expected to realize cost and growth synergies, further boosting its competitive edge in the market.
- Financial Impact: The acquisition is anticipated to be immediately accretive to adjusted earnings per share, delivering mid-single digit percentage accretion in the first year, with a long-term goal of reducing the total funded debt to adjusted EBITDA ratio to 3.0:1 or lower by 2027.
Prestige Consumer Healthcare Inc. Reports Decline in Q2 Profit, Surpassing Expectations
Earnings Report: Prestige Consumer Healthcare Inc. reported a second-quarter profit of $42.21 million, down from $54.37 million last year, but exceeded analysts' expectations of $0.97 per share with adjusted earnings of $1.07 per share.
Revenue Decline: The company's revenue decreased by 3.4% to $274.11 million compared to $283.78 million in the same quarter last year.
Earnings Per Share Comparison: The earnings per share (EPS) for the quarter was $0.86, compared to $1.09 in the previous year.
Future Guidance: Prestige Consumer Healthcare provided full-year EPS guidance of $4.54 - $4.58 and revenue guidance of $1,100 - $1,115 million.
RBC Capital Reaffirms Outperform Rating for Premium Brands Holdings, Increases Price Target to C$118
Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.
Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing their trading strategies.
Market Winning Tools: The platform provides essential tools and information to help traders succeed in the stock market.
Prestige Consumer Healthcare Q3 Earnings Miss Expectations
- Earnings Report Disappointment: Prestige Consumer Healthcare reported a Q3 non-GAAP EPS of $1.14, missing expectations by $0.02, indicating pressure on profitability that could affect investor confidence.
- Revenue Decline: Q3 revenue was $283.4 million, down 2.4% year-over-year and missing market expectations by $3.12 million, reflecting challenges in the competitive landscape.
- Fiscal 2026 Outlook Adjustment: The company revised its FY26 revenue outlook to between $1.1 billion and $1.115 billion, indicating a cautious stance on future growth with an anticipated organic revenue decline of approximately 3%.
- Stable Cash Flow: Despite challenges, the company expects free cash flow to remain at $245 million or more, demonstrating robust cash management that may support future investments.
2026 Stock Market and Economic Forecast from Barron’s Roundtable Experts
Market Concerns: Investors are increasingly worried about high valuations, index concentration, circular finance, persistent inflation, and rising government debt.
Geopolitical Developments: A significant geopolitical event occurred on January 3, with the capture of Venezuelan President Nicolás Maduro and his wife by U.S. troops, adding to market uncertainties.
Prestige Consumer Acquires Pillar5 Pharma to Expand Eye Care Product Line
- E-Commerce Growth: Prestige Consumer reported double-digit consumption growth in e-commerce channels, with online sales representing up to 20% of total sales in fiscal 2025, reflecting the success of its digital strategies and enhancing market competitiveness.
- Acquisition Fuels Growth: The company announced the acquisition of Pillar5 Pharma, expected to close in Q3 of fiscal 2026, which will enhance supply capabilities in the eye care category, securing near-term supply and expanding long-term production capacity, thereby diversifying its product portfolio.
- Stable Solvency: As of the end of Q2 fiscal 2026, Prestige Consumer reported no short-term debt and cash equivalents of $119 million, indicating a robust financial position that helps mitigate risks from economic fluctuations.
- Cost Pressure Challenges: Despite facing approximately $5 million in tariff costs and supply chain disruptions, Prestige Consumer is proactively implementing cost-saving measures and tactical pricing strategies to offset these impacts, ensuring sustained profitability.
Premium Brands Acquires Stampede for $662.5 Million
- Acquisition Agreement: Premium Brands has entered into a definitive agreement to acquire Stampede Culinary Partners for approximately $662.5 million, consisting of $512.5 million in cash and $150 million in common shares, which is expected to significantly enhance its position in the U.S. foodservice market.
- Market Expansion: This acquisition will strengthen Premium Brands' presence in the U.S. foodservice channel, particularly as its current strategies are primarily focused on retail and club store channels, thereby driving overall company growth.
- Production Capability Enhancement: By acquiring Stampede, Premium Brands will gain sous vide cooking capabilities, enhancing its production capacity and is expected to realize cost and growth synergies, further boosting its competitive edge in the market.
- Financial Impact: The acquisition is anticipated to be immediately accretive to adjusted earnings per share, delivering mid-single digit percentage accretion in the first year, with a long-term goal of reducing the total funded debt to adjusted EBITDA ratio to 3.0:1 or lower by 2027.
Prestige Consumer Healthcare Inc. Reports Decline in Q2 Profit, Surpassing Expectations
Earnings Report: Prestige Consumer Healthcare Inc. reported a second-quarter profit of $42.21 million, down from $54.37 million last year, but exceeded analysts' expectations of $0.97 per share with adjusted earnings of $1.07 per share.
Revenue Decline: The company's revenue decreased by 3.4% to $274.11 million compared to $283.78 million in the same quarter last year.
Earnings Per Share Comparison: The earnings per share (EPS) for the quarter was $0.86, compared to $1.09 in the previous year.
Future Guidance: Prestige Consumer Healthcare provided full-year EPS guidance of $4.54 - $4.58 and revenue guidance of $1,100 - $1,115 million.
RBC Capital Reaffirms Outperform Rating for Premium Brands Holdings, Increases Price Target to C$118
Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.
Exclusive Content: Subscribers gain access to unique stories and insights generated by Benzinga reporters.
Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing their trading strategies.
Market Winning Tools: The platform provides essential tools and information to help traders succeed in the stock market.
